The DOI matches its Crossref record.
Structural Characterization and Biological Functions of Fibroblast Growth Factor
Abstract
BASIC AND acidic fibroblast growth factors (FGFs) are closely related molecules that show a similar range of biological activities. They differ, however, in some of their physical and chemical properties and in their tissue distribution (1). Basic FGF [bFGF isoelectric point (pi) 9.6] was first identified by its ability to cause the proliferation and phenotypic transformation of BALB/c 3T3 fibroblasts (2, 3). Acidic FGF (aFGF, pi 5.6) was first identified by its ability to cause proliferation and delayed differentiation of myoblasts (4); it was later rediscovered on the basis of its ability to stimulate endothelial cell proliferation (5, 6). As expected from their structural relationship, both FGF and aFGF interact with the same receptor (7), thereby having similar, if not identical, properties. In contrast to aFGF, which has a cellular distribution more restricted than bFGF, many different cells synthesize bFGF, and essentially all have a specific high affinity receptor for this peptide. bFGF is thus a fundamental regulatory molecule, acting by both autocrine and paracrine mechanisms. Recent studies indicate an important role for both bFGF and aFGF in cells of vascular, nervous, and connective tissue. bFGF and aFGF are multifunctional, since they can either stimulate proliferation and induce or delay differentiation (8). They stimulate other critical processes in cell function as well. As is true for most peptide growth factors, the basic molecular mechanism of action of FGFs is at present unknown. Nevertheless, so many new and varied functions have now been described for bFGF and could be extrapolated to aFGF that, at present, one must consider these two closely related peptides to be general mediators of regulation in the cell, and one of special importance for positive control of cell growth and differentiation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
Ferrara, N., Hillan, K. J., Gerber, H.-P., & Novotny, W. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1381 · Cited by 2,625
Self-citationVEGF and the quest for tumour angiogenesis factors
Ferrara, N. (2002) · Nature Reviews Cancer · doi:10.1038/nrc909 · Cited by 1,536
Self-citationMechanisms of normal and tumor-derived angiogenesis
Papetti, M., & Herman, I. M. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00389.2001 · Cited by 809
Saksela, O., & Rifkin, D. B. (1990) · The Journal of cell biology · doi:10.1083/jcb.110.3.767 · Cited by 539
Alternatives to the use of fetal bovine serum: Serum-free cell culture
Gstraunthaler, G. (2003) · ALTEX · doi:10.14573/altex.2003.4.257 · Cited by 401
Metadata
- Authors
- GOSPODAROWICZ, D., FERRARA, N., SCHWEIGERER, L., & NEUFELD, G.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 1987-05
- Volume
- 8
- Issue
- 2
- Pages
- 95-114
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2024787221
- Cited by
- 1,273
- References
- 0
- FWCI
- 28.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Structural Characterization and Biological Functions of Fibroblast Growth Factor. https://app.cochat.ai/papers/10.1210/edrv-8-2-95
- The paper
- GOSPODAROWICZ, D., FERRARA, N., SCHWEIGERER, L., & NEUFELD, G. (1987). Structural Characterization and Biological Functions of Fibroblast Growth Factor. Endocrine Reviews. https://doi.org/10.1210/edrv-8-2-95
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.